Friday, September 25, 2015

Rebetol (ribavirin) and PegIntron (peginterferon alfa-2b) Will be Discontinued

We just heard news that the popular treatment of HCV/Hepatitis C ribavirin and peginterferon alfa will be discontinued on February 1st 2016.  These drugs were a commonly prescribed with Sovaldi (sofosbuvir 400mg).  

Ribavirin's brand name Rebetol capsules by Merck will no longer be available due to business reasons not health or treatment issues with HCV/Hepatitis C as stated by the FDA  Rebetol for patients ≥3 years of age with compensated liver disease. It is supplied as 200mg capsules in 56-, 70-, and 84-count bottles.

FDA also stated PegIntron (peginterferon alfa-2b) for injection by Merck will also be discontinued.  Again reasons are business related not safety or efficacy issues with peginterferon alfa-2b.

What will be the alternatives, maybe generic version from Canada or India. 

We will keep you updated.

No comments:

Post a Comment